| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| ISX |
Secondary MEF cells |
Treatment: DOX induction, N2B27 2i\\LIF medium, day5 Genotype: Mbd3f/- cell line |
Permissive
|
Mus musculus |
GSE102517
...
|
MA0654.1
|
| ISX |
Secondary MEF cells |
Treatment: DOX induction, N2B27 2i\\LIF medium, day6 Genotype: Mbd3f/- cell line |
Permissive
|
Mus musculus |
GSE102517
...
|
MA0654.1
|
| ISX |
Secondary MEF cells |
Treatment: DOX induction, N2B27 2i\\LIF medium, day7 Genotype: Mbd3f/- cell line |
Permissive
|
Mus musculus |
GSE102517
...
|
MA0654.1
|
| ISX |
Secondary MEF cells |
Treatment: DOX induction, N2B27 2i\\LIF medium, day8 Genotype: Mbd3f/- cell line |
Permissive
|
Mus musculus |
GSE102517
...
|
MA0654.1
|
| ISX |
induced pluripotent stem cells |
Genotype: Mbd3f/- cell line |
Permissive
|
Mus musculus |
GSE102517
...
|
MA0654.1
|
| JDP2 |
Loucy (adult T acute lymphoblastic leukemia) |
|
Permissive
|
Homo sapiens |
GSE115465
...
|
MA0655.1
...
|
| JUN |
K562 (myelogenous leukemia) |
30 m of Interferon alpha (Snyder) |
Permissive
Robust
|
Homo sapiens |
ENCSR000EGH
|
MA0488.1
...
|
| JUN |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 25 minute |
Permissive
|
Homo sapiens |
ENCSR604CKQ
|
MA0099.3
...
|
| JUN |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 10 minute |
Permissive
Robust
|
Homo sapiens |
ENCSR022WVP
|
MA0099.3
...
|
| JUN |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 15 minute |
Permissive
Robust
|
Homo sapiens |
ENCSR716SJK
|
MA0099.3
...
|
Showing 10 records in page 362
from 772 pages